MEDICUS PHARMA LTD. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MEDICUS PHARMA LTD. (MDCX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 12.79 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- 2026-06-30: Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month 12.79M shares.
- 2025-06-30: Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month 10.88M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month |
|---|---|
| 2026-06-30 | 12.79M shares 10-Q · filed 2026-08-12 |
| 2025-06-30 | 10.88M shares 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |